Enantiomeric drug development: Issues, considerations, and regulatory requirements

Citation
Nr. Srinivas et al., Enantiomeric drug development: Issues, considerations, and regulatory requirements, J PHARM SCI, 90(9), 2001, pp. 1205-1215
Citations number
60
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACEUTICAL SCIENCES
ISSN journal
00223549 → ACNP
Volume
90
Issue
9
Year of publication
2001
Pages
1205 - 1215
Database
ISI
SICI code
0022-3549(200109)90:9<1205:EDDICA>2.0.ZU;2-4